Bulis Veronica Sanchez
SEC CIK 2095702 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | VP, Corp. Ctrl | 14.8K | — | $96.9K | 6 | 2025-11-10 | 2026-08-10 |
Most active insiders at LYEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ARCH Venture Partners IX Overage, L.P. | 10% | $12.50M | — |
| 2 | BERNS PAUL L | 10% | $12.50M | — |
| 3 | Seely Lynn | Pres, CEO, Dir | — | $353.1K |
| 4 | Bulis Veronica Sanchez | VP, Corp. Ctrl | — | $96.9K |
| 5 | Lee Gary K. | CSO | — | $71.7K |
| 6 | Hill Stephen J. | COO | — | $51.3K |
| 7 | Shook David | Chief Medical Off | — | $31.3K |
| 8 | Innovative Cellular Therapeutics Holdings Ltd | 10% | — | $274.30 |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 16:21 | 2026-08-10 | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corp. Ctrl | S - Sale | $14.34 | -621 | 14.8K | -4% | -$8,905 | |
| 2026-06-15 18:32 | 2026-05-11 | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corp. Ctrl | S - Sale | $18.91 | -217 | 15.4K | -1% | -$4,103 | |
| 2026-02-11 | 2026-02-10 | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corp. Ctrl | S - Sale | $23.12 | -254 | 15.6K | -2% | -$5,872 | |
| 2026-02-11 | 2026-02-10 | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corp. Ctrl | A - Grant | $0.00 | +8,750 | 15.9K | +123% | $0 | |
| M | 2026-01-06 | 2025-12-24+ | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corp. Ctrl | S - Sale | $35.80 | -2,072 | 8,077 | -20% | -$74.2K |
| 2025-11-12 | 2025-11-10 | LYEL | Lyell Immunopharma, Inc. | Bulis Veronica Sanchez | VP, Corp. Ctrl | S - Sale | $16.10 | -239 | 9,213 | -3% | -$3,848 |
Purchase Sale Sale after option exercise All abbreviations